Open Access

Ghrelin inhibits cisplatin‑induced MDA‑MB‑231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling

  • Authors:
    • Jinyu Zhang
    • Tianhao Xie
  • View Affiliations

  • Published online on: December 31, 2019     https://doi.org/10.3892/etm.2019.8398
  • Pages: 1633-1640
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ghrelin is a multi‑functional peptide, its role on cancer cell apoptosis remains controversial. The present study examined the effects and mechanisms of ghrelin on cisplatin‑induced apoptosis in human breast cancer cells. It was identified that ghrelin inhibited apoptosis in MDA‑MB‑231 cells in vitro and reversed the expression of B‑cell lymphoma 2 (Bcl2) and Bcl2‑associated X, and cleaved caspase‑3 induced by cisplatin. Furthermore, ghrelin activated the phosphoinositide 3‑kinases/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway after cisplatin treatment. The effects of ghrelin on the cisplatin‑induced apoptosis and PI3K/Akt/mTOR signaling were reversed by the growth hormone secretagogue receptor small interfering RNA. The present study suggests that ghrelin may serve as a novel target for cisplatin resistance and a potential indicator of cisplatin sensitivity in breast cancer treatment.

Related Articles

Journal Cover

March 2020
Volume 19 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Zhang, J., & Zhang, J. (2020). Ghrelin inhibits cisplatin‑induced MDA‑MB‑231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling. Experimental and Therapeutic Medicine, 19, 1633-1640. https://doi.org/10.3892/etm.2019.8398
MLA
Zhang, J., Xie, T."Ghrelin inhibits cisplatin‑induced MDA‑MB‑231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling". Experimental and Therapeutic Medicine 19.3 (2020): 1633-1640.
Chicago
Zhang, J., Xie, T."Ghrelin inhibits cisplatin‑induced MDA‑MB‑231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling". Experimental and Therapeutic Medicine 19, no. 3 (2020): 1633-1640. https://doi.org/10.3892/etm.2019.8398